Article Details
Retrieved on: 2018-04-08 21:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Magenta, with its lofty goals of improving stem cell transplantation, has been making a splash in the big Cambridge/Boston hub, previously gathering $98.5 million in venture cash from some marquee investors that include GV — the venture group formerly known as <b>Google Ventures</b> — and in-licensing a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here